🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: Evaluated the safety and pharmacokinetics of eliglustat...
Status
Completed
Location
Investigational Site Number : 0320001
Start Date
2018-04-11
Trial ID
NCT03485677
Treatments Being Tested
The primary objective of the study is to evaluate dose proportionality and ...
Status
Completed
Location
M.D.Covance Clinical Research Unit 1341 W
Start Date
2018-01-01
Trial ID
NCT06188325
Treatments Being Tested
Primary Objective: To study the effect of mild, moderate, and severe renal...
Status
Completed
Location
Investigational Site Number 840004
Start Date
2015-09
Trial ID
NCT02536937
Treatments Being Tested
Primary Objective: To study the effect of mild and moderate hepatic impair...
Status
Completed
Location
Investigational Site Number 840002
Start Date
2015-09
Trial ID
NCT02536911
Treatments Being Tested
Objectives: To determine pharmacokinetic (PK) variables, including absolut...
Status
Completed
Location
Multiple Locations
Start Date
2009-06-03
Trial ID
NCT06143904
Treatments Being Tested
Primary Objective: The purpose of this study is to assess the palatability...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2015-04
Trial ID
NCT02422654
Treatments Being Tested
Primary Objective: Evaluate long term skeletal response to eliglustat in a...
Status
Completed
Location
Investigational Site Number 124002
Start Date
2015-10-27
Trial ID
NCT02536755
Treatments Being Tested
A study to assess the absorption of eliglustat through the mouth in healthy...
Status
Completed
Location
Covance Clinical Researsh Unit
Start Date
2014-08-25
Trial ID
NCT06193304
Treatments Being Tested